Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 126,600 | 82,400 | 35,300 | 117,200 | 85,500 |
| Depreciation Amortization | 118,800 | 77,700 | 37,100 | 137,200 | 101,200 |
| Income taxes - deferred | 11,300 | 8,700 | 400 | 73,500 | N/A |
| Accounts receivable | -1,600 | 3,900 | 7,700 | -10,900 | 800 |
| Accounts payable and accrued liabilities | -33,700 | 18,800 | -34,200 | 28,200 | -18,200 |
| Other Working Capital | 12,900 | 72,500 | 7,000 | 24,000 | 28,900 |
| Other Operating Activity | 33,300 | -24,000 | 24,200 | 4,000 | 36,900 |
| Operating Cash Flow | $267,600 | $240,000 | $77,500 | $373,200 | $235,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71,100 | -39,600 | -13,600 | -88,600 | -46,700 |
| Net Acquisitions | -97,600 | -97,600 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -34,000 | -34,000 |
| Sale Of Investment | 9,200 | 9,200 | 8,800 | 1,900 | 200 |
| Other Investing Activity | 15,800 | 15,800 | 12,300 | 5,700 | 5,800 |
| Investing Cash Flow | $-143,700 | $-112,200 | $7,500 | $-115,000 | $-74,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 315,000 | 315,000 | N/A | -240,000 | -240,000 |
| Debt Issued | 221,200 | 221,200 | N/A | 155,300 | 155,300 |
| Debt Repayment | -13,200 | -11,700 | -7,800 | -244,400 | -238,700 |
| Common Stock Issued | 47,000 | 45,700 | 2,400 | 321,700 | 316,800 |
| Dividend Paid | -778,300 | -41,000 | -19,800 | -19,800 | N/A |
| Other Financing Activity | -36,900 | -31,600 | -12,500 | -23,000 | -5,700 |
| Financing Cash Flow | $-245,200 | $497,600 | $-37,700 | $-50,200 | $-12,300 |
| Beginning Cash Position | 276,000 | 276,000 | 276,000 | 68,000 | 68,100 |
| End Cash Position | 154,700 | 901,400 | 323,300 | 276,000 | 216,200 |
| Net Cash Flow | $-121,300 | $625,400 | $47,300 | $208,000 | $148,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 267,600 | 240,000 | 77,500 | 373,200 | 235,100 |
| Capital Expenditure | -89,800 | -53,900 | -23,900 | -108,200 | -60,700 |
| Free Cash Flow | 177,800 | 186,100 | 53,600 | 265,000 | 174,400 |